Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992.
Company profile
Ticker
ELMD
Exchange
Website
CEO
Kathleen S. Skarvan
Employees
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Masimo • Natus Medical • LivaNova • Outset Medical • Fonar • Cutera • Inmode ...
SEC CIK
Corporate docs
IRS number
411732920
ELMD stock data
Latest filings (excl ownership)
8-K
Submission of Matters to a Vote of Security Holders
17 Nov 22
8-K
Electromed, Inc. Announces Fiscal 2023 First Quarter Results
8 Nov 22
10-Q
2022 Q1
Quarterly report
8 Nov 22
8-K
Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer
24 Oct 22
DEFA14A
Additional proxy soliciting materials
27 Sep 22
DEF 14A
Definitive proxy
27 Sep 22
10-K
2022 FY
Annual report
23 Aug 22
8-K
Electromed, Inc. Announces Fiscal 2022 Fourth Quarter and Full Year Financial Results
23 Aug 22
8-K
Electromed, Inc. Announces Election of Andrew Summers as Additional Independent Director
25 Jul 22
8-K
Departure of Directors or Certain Officers
7 Jun 22
Transcripts
ELMD
Earnings call transcript
2023 Q1
11 Nov 22
ELMD
Earnings call transcript
2022 Q4
24 Aug 22
ELMD
Earnings call transcript
2022 Q3
15 May 22
ELMD
Earnings call transcript
2022 Q2
8 Feb 22
ELMD
Earnings call transcript
2022 Q1
10 Nov 21
ELMD
Earnings call transcript
2021 Q4
25 Aug 21
ELMD
Earnings call transcript
2021 Q3
12 May 21
ELMD
Earnings call transcript
2021 Q2
10 Feb 21
ELMD
Earnings call transcript
2021 Q1
10 Nov 20
ELMD
Earnings call transcript
2020 Q4
25 Aug 20
Latest ownership filings
Financial summary
| Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Jun 22 | Jun 21 | Jun 20 | Jun 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 6.00 mm | 6.00 mm | 6.00 mm | 6.00 mm | 6.00 mm | 6.00 mm |
| Cash burn (monthly) | 718.33 k | 320.50 k | (no burn) | (no burn) | 564.67 k | 150.33 k |
| Cash used (since last report) | 2.80 mm | 1.25 mm | n/a | n/a | 2.20 mm | 586.09 k |
| Cash remaining | 3.20 mm | 4.75 mm | n/a | n/a | 3.80 mm | 5.41 mm |
| Runway (months of cash) | 4.5 | 14.8 | n/a | n/a | 6.7 | 36.0 |
Institutional ownership, Q3 2022
42.1% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 35 |
| Opened positions | 3 |
| Closed positions | 10 |
| Increased positions | 12 |
| Reduced positions | 9 |
| 13F shares | Current |
|---|---|
| Total value | 31.27 mm |
| Total shares | 3.57 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Summers Value Fund | 521.69 k | $0.00 |
| George H. Winn | 446.30 k | $4.38 mm |
| Punch & Associates Investment Management | 415.27 k | $4.26 mm |
| Zenith Sterling Advisers | 395.57 k | $4.19 mm |
| Vanguard | 300.84 k | $3.08 mm |
| Dimensional Fund Advisors | 276.76 k | $2.84 mm |
| Acadian Asset Management | 259.81 k | $2.66 mm |
| Bridgeway Capital Management | 108.74 k | $1.12 mm |
| RY Royal Bank Of Canada | 100.59 k | $1.03 mm |
| White Pine Capital | 96.21 k | $986.00 k |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Dec 22 | Kathleen A Tune | Common Stock | Grant | Acquire A | No | No | 0 | 3,000 | 0.00 | 6,000 |
| 1 Dec 22 | Andrea M. Walsh | Common Stock | Grant | Acquire A | No | No | 0 | 3,000 | 0.00 | 9,000 |
| 1 Dec 22 | A Jones Lee | Common Stock | Grant | Acquire A | No | No | 0 | 3,000 | 0.00 | 28,183 |
| 1 Dec 22 | Andrew Summers | Common Stock | Grant | Acquire A | No | No | 0 | 3,000 | 0.00 | 3,000 |
| 1 Dec 22 | Gregory Fluet | Common Stock | Grant | Acquire A | No | No | 0 | 3,000 | 0.00 | 12,000 |
News
Lake Street Assumes Electromed at Buy, Announces Price Target of $20
28 Dec 22
Electromed, Inc. Announces U.S. FDA 510(k) Clearance Of Fifth Generation HFCWO Airway Clearance Generator
30 Nov 22
Electromed Q1 EPS $0.01 Misses $0.03 Estimate, Sales $10.66M Miss $10.70M Estimate
8 Nov 22
Earnings Scheduled For November 8, 2022
8 Nov 22